Sponsor

AO GENERIUM

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name AO GENERIUM appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials6
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

6 shown
Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid ArthritisNCT06475508 · lead sponsor · 2023-02-13
COMPLETED
A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy VolunteersNCT06494345 · lead sponsor · 2023-01-15
COMPLETED
A Phase 1 Study of GNR-051 in Subjects With Advanced MalignanciesNCT04544748 · lead sponsor · 2020-07-22
COMPLETED
An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial AsthmaNCT04607629 · lead sponsor · 2018-06-20
COMPLETED
Study of Pharmacokinetics, Pharmacodynamics and Safety Assessment of GNR-044 (JSC GENERIUM, Russia) and Xolair®NCT04601389 · lead sponsor · 2017-04-18
COMPLETED
Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial InfarctionNCT07146360 · lead sponsor · 2014-05-25
COMPLETED

Sponsor roles

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.